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Imaging of the serotonin transporter before and after citalopram administration in 
canine brain with 123I-betaCIT SPECT. 
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The serotonergic system has been implicated in mood and anxiety disorders, 
schizophrenia and eating and impulsive disorders.  Selective serotonine reuptake 
inhibitors (SSRI) are used to elevate the synaptic serotine by blocking the serotonine 
transporter (SERT), mainly located in the raphe nuclei in the midbrain. A dog model 
has been proposd to investigate disorders concerning the serotonergic system in 
previous studies.  
 
Aim:  
(1) To investigate the feasibility to image the serotonine transporter with 123I-beta-
CIT SPECT in the dog and (2) to determine the feasibility to block this SERT with 
citalopram HCl, a frequently used SSRI. 
 
Materials and methods:  
Two female dogs, aged 2 and 6 years, a german shepherd and a bull mastiff, were 
included. 
Two investigations were performed in each dog, one control study and one blocking 
study with citalopram, administered by IV infusion (spread over 30 minutes), 10 
minutes prior to injection of the tracer.  Acquisition was performed under general 
anaesthesia (including detomidine as a sedative, induction of the general anaesthesia 
with propofol and maintenance with halothane) 3 hours after injection of the tracer. 
The acquisition for both investigations was performed with a Toshiba triple head 
gamma camera, equipped with fan-beam collimators.  A 153-Gadolinium 
transmission scan was acquired before the emission scans.  
The images were reconstructed with filtered back projection after 
rebinning to parallel data and applying a Butterworth-filter (cut-off 0.16 
cycli/pixel, order 8). Uniform Sorensen attenuation correction with an 
attenuation coefficient of 0.12 /cm and triple-energy window scatter 
correction were applied.   
Co-registration with MRI images, obtained from both dogs on a separate occasion, 
facilitated recognition of the raphe nuclei. 
 
Results:  
SERT were identified in the brain of the dog with 123I-betaCIT.  Administration of 
citalopram prior to the tracer, effectively blocked the SERT. 
 
Conclusion: 
Recognition of the SERT in the dog brain paves the way to further evaluate the 
serotonergic system as a model for human disease and to monitor interactions with 
commonly used medication. 
 
   
